Ardeparin

N/A

Report date: 2025/07/18 17:32:45
NME

Base Information

Drug NameArdeparin
Drug Alias NameArdeparin sodiumNormiflo
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionAntithrombin-III activatorsFactor Xa inactivationThrombin inactivation
TargetsAntithrombin-IIIProthrombinCoagulation factor X
Therapy Area/IndicationsVenous ThrombosisPulmonary Embolism
Global Approved IndicationsVenous ThrombosisPulmonary Embolism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1997/05/01
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesWyeth-Ayerst
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsVenous ThrombosisPulmonary Embolism
Inactive IndicationsN/A

Other Information

ATC CodeB01AB
Related LinksWikipediaDrugBank